Overview
?
Harald Hasselmann
See more contacts
Management of Companies and Enterprises
,
Medical Equipment and Supplies Manufacturing
,
Basic Chemical Manufacturing
,
Chemical and Allied Products Merchant Wholesalers
,
Holding companies, nec
See All Industries , Surgical and medical instruments , Isotopes, radioactive Chemicals and allied products, nec
See Fewer Industries
See All Industries , Surgical and medical instruments , Isotopes, radioactive Chemicals and allied products, nec
See Fewer Industries
?
?
Actual
$312.86 million
Actual
20.22%
26.52%
$442
DEC
?
?
XETRA:EUZ
Contacts
Get in Touch with 15 Principals*
-
Harald HasselmannChief Executive Officer
-
Contact 2?
-
Contact 3?
-
Contact 4?
Dynamic search and list-building capabilities
Real-time trigger alerts
Comprehensive company profiles
Valuable research and technology reports
Financial Statements
Dun & Bradstreet collects private company financials for more than 23 million companies worldwide. Find out more.
Financial data as of December 31, 2024 (12 month period) in USD
Annual Revenue 2024
$312.86 million
USD
Actual
1 USD = 0.9456 EUR
All financial statement data is in millions except per share data | Source: Morningstar
| Cash Flow (mil) | 2024 | 2023 | 2022 |
|---|---|---|---|
| Net Operating Cash | $70 | $50 | $36 |
| Net Investing Cash | -$18 | -$45 | -$43 |
| Net Financing Cash | -$11 | -$10 | -$6 |
| Net Change in Cash | $42 | -$5 | -$13 |
| Cash at Beginning of Period | $82 | $87 | $99 |
| Cash at End of Period | $125 | $82 | $87 |
| Capital Expenditure | -$18 | -$28 | -$29 |
| Assets (mil) | 2024 | 2023 | 2022 |
|---|---|---|---|
| Current Assets | |||
| Cash and Cash Equivalents | $125 | $72 | $87 |
| Accounts Receivable | $46 | $46 | $39 |
| Inventories | $46 | $42 | $42 |
| Other Current Assets | $21 | $87 | $16 |
| Asset Summary | |||
| Total Current Assets | $238 | $247 | $184 |
| Tangible Fixed Assets | $139 | $118 | $118 |
| Intangible Assets | $13 | $14 | $57 |
| Total Assets | $442 | $439 | $407 |
| Liabilities (mil) | 2024 | 2023 | 2022 |
|---|---|---|---|
| Current Liabilities | |||
| Accounts Payable | $10 | $6 | $9 |
| Short-Term Debt | $7 | $7 | $ |
| Other Current Liabilities | $60 | $76 | $51 |
| Liability Summary | |||
| Total Current Liabilities | $76 | $88 | $60 |
| Long-Term Debt | $15 | $21 | $24 |
| Other Long-Term Liabilities | $2 | $2 | $11 |
| Total Liabilities | $230 | $228 | $205 |
| Stakeholder's Equity (mil) | 2024 | 2023 | 2022 |
|---|---|---|---|
| Equity | |||
| Common Stock | $22 | $22 | $22 |
| Retained Earnings | $135 | $147 | $130 |
| Equity Summary | |||
| Total Equity | $236 | $235 | $224 |
| Shares Outstanding | 20,845,698 | 20,826,355 | 20,795,426 |